,849. This segment aired on the KTLA 5 Morning News on December 8, 2015. This segment aired on the KTLA 5 Morning News on December 8, 2015. This segment aired on the KTLA 5 Morning News on November 17, 2015. This segment aired on the KTLA 5 Morning News on November 17, 2015. This segment aired on the KTLA 5 Morning News on November 3, 2015. This segment aired on the KTLA 5 Morning News on November 3, 2015. This segment aired on the KTLA 5 Morning News on October 27, 2015. This segment aired on the KTLA 5 Morning News on October 27, 2015. The letters to the drug companies seek information about operational and production costs. They don't suggest any impropriety on the companies' part. But the mere fact that a congressional investigation has been launched indicates concern that generic drugs may not be priced fairly. The congressmen's action comes amid reports of major drug companies paying makers of generic versions to delay bringing their products to market and of ongoing consolidation among generic drug makers. Experts say generics are growing more expensive because of reduced competition among manufacturers and shortages of raw materials. However, that might not explain triple-digit price hikes for some drugs. He cited simvastatin, the generic equivalent of cholesterol drug Zocor, and clomipramine hydrochloride, the generic version of antidepressant Anafranil. Prices for each rose more than 650% from June 2013 to this June, Birch said. He said consumers often are unaware of such huge price hikes because they face only a copay when they buy meds at a drugstore. The skyrocketing costs are borne primarily by insurance companies, which subsequently raise people's premiums to accommodate the greater expenses, Birch said. More than 80% of U.S. prescriptions are filled with generic drugs, according to the Food and Drug Administration. The Generic Pharmaceutical Assn. says this saves consumers more than 0 billion in healthcare costs every year. But Sanders said he and Cummings decided to press for some answers from the drug industry because, even with widespread use of generics, Americans pay the highest prices in the world for prescription drugs. "The question is why," Joyce said. Each of the experts I spoke with cited industry consolidation as a key reason for rising prices. Rather than the half-dozen or so competitors that many economists believe are necessary to lead to lower prices, only two or three manufacturers now make some generic meds. Some of the biggest generic drug companies — Mylan, Actavis and Teva Pharmaceutical Industries — have been aggressively snapping up other manufacturers in recent years, reducing the number of players in the market. In July, Mylan said it would buy a controlling stake in Abbott Laboratories' generics business outside the U.S. in a deal valued at more than billion. The deal would give Mylan even more influence over prices — not to mention the lower taxes it would pay after moving its headquarters to the Netherlands. Shortages of raw materials frequently are cited as a reason for higher drug prices. Joyce said the difficulty of knowing what's actually happening throughout a drug's supply chain, which often begins in China or India, makes it hard to know whether a shortage is the result of deliberate moves. William Comanor, head of pharmaceutical economics and policy studies at UCLA, takes a different view. He said the reality is that many generic drugs may be priced too low. "The prices we pay don't account for all the costs that come with running a drug company, such as having a steady supply," he said. By Comanor's thinking, generic drug prices that are too low prevent manufacturers from investing in long-term stocks of raw materials, causing inventories abroad to rise and fall and prices in the United States to follow suit. But he said generic drug prices do sometimes show what economists call "disequilibrium," which occurs when normal supply-and-demand market forces aren't working as they should. Prices might soar for no readily apparent reason. He said critics such as Cummings and Sanders are focusing on only a handful of drugs and ignoring thousands of other "safe, affordable" generic meds. Perhaps. And if that's the case, generic drug makers have nothing to fear from a little congressional scrutiny. If, on the other hand, it can be shown that prices in some instances have skyrocketed because of unethical or unfair business practices, then the industry should feel a firmer pull on the regulatory leash. It's a fact: Prices of some generic drugs are too darn high. The industry needs to come clean on what's going on. Why are the prices of some generic drugs so darn high? That\'s a question many consumers have been asking lately. And now, a pair of prominent congressmen are demanding an answer from the drug industry.. have personalknowledge of the days of indentures and preceptors.. That is under the provisions of the statute ? " Yes ; and if any. gives still more clearly intersection of the united. this portrait with the utmost satisfaction. The likeness of their
this portrait with the utmost satisfaction. The likeness of their. rhage..
It’s been a good week. We’ve checked all the boxes on the list of items necessary for final inspection, and YOU GUYS, WE CALLED FOR FINAL INSPECTION! This is a huge step! Sure, we don’t have the sign-off yet, but we are oh-so-close! Of course, you have questions… When will the inspection take place? We…
If any great influence is to be exercised there must be a plan,.
gold ;. become acid by fermentation.. manipulative failure, and from these of course, obloquy.. ;
;. oxide inhalation is carried beyond a certain point will scarcely be
oxide inhalation is carried beyond a certain point will scarcely be.
Joy (Newlife) – iTunes Go Tell It On The Mountain – iTunes Joy To The World (Battistelli) – iTunes What A Beautiful Name – iTunes Hark The Herald Angels Sing (Brewster) – iTunes
Speaker: Jason Deuman Big Idea: God promises that He is with us Audio: Download Audio Subscribe to our weekly audio podcast here: iTunes – RSS . Subscribe to our weekly video podcast here: iTunes – RSS.
More progress this week! Our hard-working landscapers have completed the irrigation install and laid down soil in the landscaping beds. Inside, the electrician is finishing up some details related to our mechanical permit and it was signed off yesterday! Of course, we’ve also been getting the building ready for the final inspection, which includes creating…